Genmab”s Epcoritamab BLA Application a Positive for AbbVie – Morgan Stanley

Friday, 1 July 2022, 22:12:10
https://www.investing.com/news/stock-market-news/genmabs-epcoritamab-bla-application-a-positive-for-abbvie–morgan-stanley-2843303
— Investing.com

AbbVie (ABBV): Buy This Dividend King For Growing Income Stream

Friday, 1 July 2022, 10:28:11
AbbVie delivered mid-single-digit revenue growth and high-single-digit adjusted diluted EPS in Q1. See why I still believe ABBV stock is a buy.
— Seeking Alpha

Uveitis Drugs Market Trend Analysis by 2022: Growth Prospective, Regional Demand, Product End-users and Forecast to 2028 | AbbVie Inc., Alimera Sciences Inc.

Thursday, 30 June 2022, 09:06:01
The SMI released the latest competent intelligence market research report on Uveitis Drugs Market, The report aims to provide a thorough and accurate analysis of the global Uveitis Drugs market, taking into account market forecast, competitive intelligence, technical risks, innovations,
— OpenPR

Check Out What Whales Are Doing With ABBV

Wednesday, 29 June 2022, 19:04:50
Someone with a lot of money to spend has taken a bullish stance on AbbVie (NYSE: ABBV ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don”t know. But when something this big happens with ABBV, it often means somebody knows something is about to happen. So how do we know what this whale just did? Today, Benzinga ”s options scanner spotted 18 uncommon options trades for AbbVie. This isn”t normal. The overall sentiment of these big-money traders is split between 61% bullish and 38%, bearish. Out of all of the special options we … Full story available on Benzinga.com
— Benzinga

Analyzing AbbVie”s Short Interest

Wednesday, 29 June 2022, 15:03:32
AbbVie”s (NYSE: ABBV ) short percent of float has risen 27.78% since its last report. The company recently reported that it has 13.52 million shares sold short , which is 0.92% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.9 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price … Full story available on Benzinga.com
— Benzinga